Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Quality of life as outcome measures in randomized clinical trials

Identifieur interne : 002F63 ( Main/Exploration ); précédent : 002F62; suivant : 002F64

Quality of life as outcome measures in randomized clinical trials

Auteurs : Sander J. O. Veldhuyzen Van Zanten [Canada]

Source :

RBID : ISTEX:D3A54F0000F8B737B779301129E9DB13B77F6447

English descriptors

Abstract

Abstract: A survey of 75 randomized trials published in 1986 in the Annals of Internal Medicine, American Journal of Medicine, and New England Journal of Medicine was carried out by two observers using predetermined criteria about the importance of health status as an outcome measurement and the quality-of-health status measurement that was used. The kappa statistic was used to measure agreement among the two observers. Although a number of investigators used well-established quality-of-life measurements, in only 10 of 55 trials in which health status was judged crucial or important were measures with established validity and responsiveness used. Despite the fact that reliable measurement of quality of life is now feasible, it is underutilized in randomized clinical trials.

Url:
DOI: 10.1016/S0197-2456(05)80027-3


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Quality of life as outcome measures in randomized clinical trials</title>
<author>
<name sortKey="Veldhuyzen Van Zanten, Sander J O" sort="Veldhuyzen Van Zanten, Sander J O" uniqKey="Veldhuyzen Van Zanten S" first="Sander J. O." last="Veldhuyzen Van Zanten">Sander J. O. Veldhuyzen Van Zanten</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D3A54F0000F8B737B779301129E9DB13B77F6447</idno>
<date when="1991" year="1991">1991</date>
<idno type="doi">10.1016/S0197-2456(05)80027-3</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-WK5P7LWX-W/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000357</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000357</idno>
<idno type="wicri:Area/Istex/Curation">000357</idno>
<idno type="wicri:Area/Istex/Checkpoint">001D34</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001D34</idno>
<idno type="wicri:doubleKey">0197-2456:1991:Veldhuyzen Van Zanten S:quality:of:life</idno>
<idno type="wicri:Area/Main/Merge">003030</idno>
<idno type="wicri:Area/Main/Curation">002F63</idno>
<idno type="wicri:Area/Main/Exploration">002F63</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Quality of life as outcome measures in randomized clinical trials</title>
<author>
<name sortKey="Veldhuyzen Van Zanten, Sander J O" sort="Veldhuyzen Van Zanten, Sander J O" uniqKey="Veldhuyzen Van Zanten S" first="Sander J. O." last="Veldhuyzen Van Zanten">Sander J. O. Veldhuyzen Van Zanten</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Medicine, Dalhousie University, Halifax, Nova Scotia</wicri:regionArea>
<wicri:noRegion>Nova Scotia</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Controlled Clinical Trials</title>
<title level="j" type="abbrev">CCT</title>
<idno type="ISSN">0197-2456</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1991">1991</date>
<biblScope unit="volume">12</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="supplement">S</biblScope>
<biblScope unit="page" from="S234">S234</biblScope>
<biblScope unit="page" to="S242">S242</biblScope>
</imprint>
<idno type="ISSN">0197-2456</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0197-2456</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Quality-of-life measures, literature survey, kappa, random allocation</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Acute asthma</term>
<term>Acute leukemia</term>
<term>American journal</term>
<term>Cancer patients</term>
<term>Clinical importance</term>
<term>Clinical trials</term>
<term>Combination chemotherapy</term>
<term>Daily activities</term>
<term>Dalhousie university</term>
<term>Diseasespecific measure</term>
<term>Donor bone marrow</term>
<term>Early discharge</term>
<term>Engl</term>
<term>England journal</term>
<term>Functional status</term>
<term>Health profile</term>
<term>Health status</term>
<term>Heart failure</term>
<term>Intern</term>
<term>Internal medicine</term>
<term>Marrow transplantation</term>
<term>Measure quality</term>
<term>Nonulcer dyspepsia</term>
<term>Nova scotia</term>
<term>Optimal treatment decision</term>
<term>Orthostatic hypotension</term>
<term>Prospective trial</term>
<term>Randomized</term>
<term>Randomized trial</term>
<term>Randomized trials</term>
<term>Rheumatoid arthritis</term>
<term>Stable stroke</term>
<term>Study group</term>
<term>Therapeutic benefit</term>
<term>Treatment decisions</term>
<term>Treatment recommendations</term>
<term>Utility measurement</term>
<term>Veterans administration</term>
<term>Weighted kappa</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: A survey of 75 randomized trials published in 1986 in the Annals of Internal Medicine, American Journal of Medicine, and New England Journal of Medicine was carried out by two observers using predetermined criteria about the importance of health status as an outcome measurement and the quality-of-health status measurement that was used. The kappa statistic was used to measure agreement among the two observers. Although a number of investigators used well-established quality-of-life measurements, in only 10 of 55 trials in which health status was judged crucial or important were measures with established validity and responsiveness used. Despite the fact that reliable measurement of quality of life is now feasible, it is underutilized in randomized clinical trials.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
</list>
<tree>
<country name="Canada">
<noRegion>
<name sortKey="Veldhuyzen Van Zanten, Sander J O" sort="Veldhuyzen Van Zanten, Sander J O" uniqKey="Veldhuyzen Van Zanten S" first="Sander J. O." last="Veldhuyzen Van Zanten">Sander J. O. Veldhuyzen Van Zanten</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002F63 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002F63 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:D3A54F0000F8B737B779301129E9DB13B77F6447
   |texte=   Quality of life as outcome measures in randomized clinical trials
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021